Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats
The Journal of Physiology · 2024-08 · 602 (15) · 3621-3639
DOI: 10.1113/jp285793 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, online erschienen am 09.07.2024. Verfasst von Fatma H Rizk und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Faculty of Medicine, Tanta University, Tanta, Egypt. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Letrozole, Gastrointestinal Microbiome. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Growing evidence supports the role of gut microbiota in chronic inflammation, insulin resistance (IR) and sex hormone production in polycystic ovary syndrome (PCOS). Adropin plays a pivotal role in the regulation of glucose and lipid metabolism and is negatively correlated with IR, which affects intestinal microbiota and sex hormones. However, the effect of adropin administration in PCOS has yet to be investigated. The present study aimed to assess the effects of adropin on letrozole (LTZ)‐induced PCOS in rats and the potential underlying mechanisms. The experimental groups were normal, adropin, letrozole and LTZ + adropin. At the end of the experiment, adropin significantly ameliorated PCOS, as evidenced by restoring the normal ovarian structure, decreasing the theca cell thickness in antral follicles, as well as serum testosterone and luteinizing hormone levels and luteinizing hormone/follicle‐stimulating hormone ratios, at the same time as increasing granulosa cell thickness in antral follicles, oestradiol and follicle‐stimulating hormone levels. The ameliorating effect could be attributed to its effect on sex hormone‐binding globulin, key steroidogenic genes STAR and CYP11A1 , IR, lipid profile, gut microbiota metabolites–brain–ovary axis components (short chain fatty acids, free fatty acid receptor 3 and peptide YY), intestinal permeability marker (zonulin and tight junction protein claudin‐1), lipopolysaccharides/Toll‐like receptor 4/nuclear factor kappa B inflammatory pathway and oxidative stress makers (malondialdehyde and total antioxidant capacity). In conclusion, adropin has a promising therapeutic effect on PCOS by regulating steroidogenesis, IR, lipid profile, the gut microbiota inflammatory axis and redox homeostasis. image Key points Adropin treatment reversed endocrine and ovarian morphology disorders in polycystic ovary syndrome (PCOS). Adropin regulated the ovarian steroidogenesis and sex hormone‐binding globulin in PCOS. Adropin improved lipid profile and decreased insulin resistance in PCOS. Adropin modulated the components of the gut–brain–ovary axis (short chain fatty acids, free fatty acid receptor 3 and peptide YY) in PCOS. Adropin improved intestinal barrier integrity, suppressed of lipopolysaccharides/Toll‐like receptor 4/nuclear factor kappa B signalling pathway and oxidative stress in PCOS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Faculty of Medicine, Tanta University, Tanta, Egypt.
- Department of Pharmacology, Faculty of Medicine, Tanta University, Tanta, Egypt.
- Department of Medical Biochemistry, Faculty of Medicine, Tanta University, Tanta, Egypt.
- Department of Anatomy and Embryology, Faculty of Medicine, Tanta University, Tanta, Egypt.
- Department of Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
- Department of Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt.
ORCID-Profile: Muhammad T Abdel Ghafar, Heba Faheem
Zitieren
APA
Rizk, F. H., El Saadany, A. A., Elshamy, A. M., Abd Ellatif, R. A., El-Guindy, D. M., Helal, D. S., Hamama, M. G., El-Sharnoby, J. A. E., Abdel Ghafar, M. T., & Faheem, H. (2024). Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats. The Journal of Physiology, 602(15), 3621-3639. https://doi.org/10.1113/jp285793
Vancouver
Rizk FH, El Saadany AA, Elshamy AM, Abd Ellatif RA, El-Guindy DM, Helal DS, et al. Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats. The Journal of Physiology. 2024;602(15):3621-3639. doi:10.1113/jp285793
BibTeX
@article{Rizk2024,
author = {Rizk, Fatma H and El Saadany, Amira A and Elshamy, Amira Mostafa and Abd Ellatif, Rasha A and El-Guindy, Dina M and Helal, Duaa S and Hamama, Mohamed G and El-Sharnoby, Jehan Abd El-Hameed and Abdel Ghafar, Muhammad T and Faheem, Heba},
title = {Ameliorating effects of adropin on letrozole‐induced polycystic ovary syndrome via regulating steroidogenesis and the microbiota inflammatory axis in rats},
journal = {The Journal of Physiology},
year = {2024},
volume = {602},
number = {15},
pages = {3621--3639},
doi = {10.1113/jp285793}
}
EUVIMED